Sign Out
Sevelamer carbonate (Renvela) tablets are supplied as white to off-white oval tablet, engraved with "RV800" on one side.
Each film-coated tablet contains: Sevelamer carbonate 800 mg on an anhydrous basis.
Renvela contains sevelamer, a non-absorbed phosphate binding cross-linked polymer, free of metal and calcium. Sevelamer carbonate (Renvela) was developed as a pharmaceutical alternative to Sevelamer hydrochloride in which carbonate replaces chloride as the counterion. While the counterions differ from the two salts the polymer itself, the active moiety involved in phosphate binding, is the same.
Excipients/Inactive Ingredients: Tablet core: Microcrystalline cellulose, Sodium chloride, Zinc stearate.
Film-coating: Hypromellose (E464), Diacetylated monoglycerides.
Printing ink: Iron oxide black (E172), Propylene glycol, Isopropyl alcohol, Hypromellose (E464).
Continue with Google